| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.47 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |